Yali Zhou
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
Papers in
-
- RNA modifications and cancer 5
- Co-authors
- Hui Zheng (3 shared papers)Guangjin Pan (1 shared paper)Duanqing Pei (1 shared paper)Jun Li (1 shared paper)Zhaoyang Wang (6 shared papers)Peiquan Zhao (4 shared papers)Handong Wang (3 shared papers)Songxia Quan (5 shared papers)
- Journals
- Scientific Reports (5 papers)Blood (3 papers)Experimental Biology and Medicine (3 papers)Plant Physiology and Biochemistry (2 papers)Cellular Physiology and Biochemistry (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yali Zhou
113 papers receiving 3.1k citations
Yali Zhou's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 402
- Nephrology 153
- Molecular Biology 1.3k
- Genetics 142
- Oncology 334
Countries citing papers authored by Yali Zhou
This map shows the geographic impact of Yali Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Zhou more than expected).
Fields of papers citing papers by Yali Zhou
This network shows the impact of papers produced by Yali Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Zhou. The network helps show where Yali Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Yali Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Hit paper breakdown → | 2021 | 216 |
| 2 | 2006 | 187 | |
| 3 | 2017 | 165 | |
| 4 | 2017 | 163 | |
| 5 | NCOA4-mediated ferritinophagy is involved in ionizing radiation-induced ferroptosis of intestinal epithelial cells Hit paper breakdown → | 2022 | 155 |
| 6 | 2012 | 93 | |
| 7 | 2018 | 88 | |
| 8 | 2020 | 84 | |
| 9 | 2017 | 82 | |
| 10 | 2021 | 80 | |
| 11 | 2020 | 78 | |
| 12 | 2016 | 74 | |
| 13 | 2019 | 67 | |
| 14 | 2016 | 59 | |
| 15 | 2018 | 59 | |
| 16 | 2009 | 54 | |
| 17 | 2018 | 53 | |
| 18 | 2013 | 52 | |
| 19 | 2017 | 49 | |
| 20 | 2018 | 45 |
About Yali Zhou
Yali Zhou is a scholar working on Molecular Biology, Plant Science, Cancer Research, Hematology and Oncology, having authored 116 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lipid metabolism and biosynthesis (7 papers), MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers), Hemoglobinopathies and Related Disorders (5 papers), CAR-T cell therapy research (5 papers), Complement system in diseases (4 papers), Iron Metabolism and Disorders (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (402 citations), Nephrology (153 citations), Molecular Biology (1.3k citations), Genetics (142 citations) and Oncology (334 citations). Yali Zhou has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Hui Zheng, Guangjin Pan, Duanqing Pei, Jun Li, Zhaoyang Wang, Peiquan Zhao, Handong Wang, Songxia Quan, Yihao Zhu and Xiaoping Zhang. Their work appears in journals such as Scientific Reports, Blood, Experimental Biology and Medicine, Plant Physiology and Biochemistry and Cellular Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.